Search Results
Dr. Smith on Frontline Treatment Considerations in CLL
Dr. Smith on Using Venetoclax Versus Ibrutinib in CLL
Dr. Smith on the Rationale Behind the Fixed Duration Trial for Ibrutinib/Venetoclax in CLL
Selecting Frontline Therapy for CLL
Dr. Smith on PI3K Inhibitors in CLL
Ibrutinib’s Role as Frontline Therapy in CLL
Dr. Furman on Frontline Treatment Selection in CLL
CLL Treatment: What Are Your Current Options?
What is the current standard of care for frontline treatment of chronic lymphocytic leukemia (CLL)?
CLL Frontline Options
Dr. Smith on Emerging Therapies in Indolent Lymphoma
Managing Complications of Standard CLL Treatments